Analysis of classes used in the treatment of depression by physician-reported severity.
We analyzed use of therapeutic drug classes for the treatment of depression by the three levels of physician-reported disease severity (mild, moderate, and severe) to understand if the mix of therapeutic classes used to treat depression changes as disease severity increases. Prior to analyzing drug...
| Publicado en: | Psychiatry (1550-5952) Vol. 7; no. 2; pp. 17 - 23 |
|---|---|
| Autores principales: | , , |
| Formato: | tables/charts Journal Article |
| Publicado: |
Matrix Medical Communications, LLC
Feb2010
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105156059&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 105156059 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15505952 32GJ jtl: Psychiatry (1550-5952) issn: 15505952 maglogo: N pubinfo: dt: Feb2010 vid: 7 iid: 2 pid: 33670 pub: Matrix Medical Communications, LLC place: West Chester, Pennsylvania artinfo: ui: 105156059 105156059 2010605729 105156059 ppf: 17 ppct: 6 formats: fmt: @attributes: type: P tig: atl: Analysis of classes used in the treatment of depression by physician-reported severity. aug: au: Lenderts S Kalali AH Weisler R affil: Manager, Strategic Analytics, Quintiles Commercial, Falls Church, Virginia sug: subj: Antidepressive Agents Classification Antidepressive Agents Therapeutic Use Depression Classification Depression Drug Therapy Severity of Illness Antianxiety Agents, Benzodiazepine Therapeutic Use Antipsychotic Agents Therapeutic Use Prescribing Patterns Trends Serotonin Uptake Inhibitors Therapeutic Use ab: We analyzed use of therapeutic drug classes for the treatment of depression by the three levels of physician-reported disease severity (mild, moderate, and severe) to understand if the mix of therapeutic classes used to treat depression changes as disease severity increases. Prior to analyzing drug uses in each severity category, we established that in the 12 months ending November 2009, the majority of patients (65%) were assigned a severity rating of 'moderate' by their physician; 27 percent and eight percent of patients were designated as 'mild' and 'severe,' respectively. In general, we found that as disease severity changes, so too do the proportions of the various therapeutic classes used in depression. The differences in class mix by severity have persisted at least since the 12 months ending December 2008, and it appears that the mix of drug classes used in severe depression are becoming less similar to the class mix for moderate depression over time. pubtype: Academic Journal doctype: tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|